Docetaxel

Страна: Нова Зеландия

Език: английски

Източник: Medsafe (Medicines Safety Authority)

Активна съставка:

Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg

Предлага се от:

REX Medical Ltd

INN (Международно Name):

Docetaxel trihydrate 25.177 mg (equivalent to anhydrous docetaxel 20mg)

дозиране:

20 mg/mL

Лекарствена форма:

Concentrate for infusion

Композиция:

Active: Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Броя в опаковка:

Vial, glass, Diluent, 1.5 mL

Клас:

Prescription

Вид предписание :

Prescription

Произведено от:

Cipla Ltd

Терапевтични показания:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Каталог на резюме:

Package - Contents - Shelf Life: Vial, glass, Diluent - 1.5 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 20 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Дата Оторизация:

2006-06-23